Conclusion
comorbidity, anxiety disorder
The current study findings showed that increased anxiety disorder comorbidity influenced the cost-effectiveness of tCBT + TAU vs. TAU from a limited societal perspective. Evaluating the cost-effectiveness of tCBT added to treatment as usual in populations with different anxiety disorder comorbidities and settings is needed to improve timely access to quality mental health resources.